Income StatementBalance SheetCash FlowSegments
Loews logo

Loews Income Statement

Revenue, expenses, and profitability over time

Loews generated $18.5B in trailing twelve-month revenue, up 0.0% year-over-year. Net income was $1.6B with a 8.83% net margin. Diluted EPS is $7.87, which grew 0.3% year-over-year. Based on the Q1 2026 filing.

Total Revenue (TTM)$18.5BNet Income (TTM)$1.6BEps Diluted (TTM)$7.87
Latest FilingQ1 2026
Report Date2026-05-04
Market Cap$22.2B
P/E Ratio13.60
ROE9.1%

Earnings Per Share

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Weighted Average Diluted Shares Adjustment—$150.0K$120.0K$140.0K—$90.0K
Basic earnings per share$0.87$1.74$1.87$2.43$1.95$1.63
Diluted earnings per share$0.87$1.74$1.87$2.43$1.94$1.63
Weighted Average Diluted Shares Adjustment—$150.0K$120.0K$140.0K—$90.0K
Weighted average number diluted shares outstanding adjustment—$150.0K$120.0K$140.0K—$90.0K
Weighted-average shares, basic—212.5M209.2M207.6M—206.2M
Weighted-average shares, diluted—212.6M209.4M207.7M—206.3M

Other

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Capital Expenditures$174.0M$98.0M$134.0M$156.0M$191.0M$204.0M
Change in Other Liabilities-$63.0M$27.0M-$19.0M-$242.0M-$40.0M-$406.0M
Benefits, Losses and Expenses$4.4B$4.0B$4.0B$4.0B$4.2B$4.1B
Deferred taxes-$11.3M$28.0M$28.0M$28.0M$28.0M—
Deferred Policy Acquisition Costs, Amortization Expense$462.0M$471.0M$469.0M$483.0M$475.0M$476.0M
Income (Loss) from Equity Method Investments, Net of Dividends or Distributions$16.5M-$2.3M-$2.3M-$2.3M-$2.3M—
Increase (Decrease) in Deferred Policy Acquisition Costs$24.0M$37.0M$12.0M—$1.0M$24.0M
Increase Decrease In Insurance Liabilities$806.0M$656.0M$758.0M$108.0M$148.0M$446.0M
Increase (Decrease) in Other Operating Assets-$543.0M$92.0M$54.0M-$132.0M-$237.0M-$83.0M
Other liabilities-$63.0M$27.0M-$19.0M-$242.0M-$40.0M-$406.0M
Increase (Decrease) in Debt Securities, Trading, and Equity Securities, FV-NI—$144.0M-$163.0M$187.0M$245.0M$582.0M
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation-$976.0M-$520.0M-$322.0M—-$79.0M-$714.0M
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation$0.0-$204.0M-$809.0M-$1.2B-$611.0M$994.0M
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation$941.0M$736.0M$1.0B$920.0M$617.0M$72.0M
Net Investment Income$696.0M$608.0M$714.0M$743.0M$714.0M$613.0M
Non-insurance Warranty Expense$378.0M$385.0M$384.0M$377.0M$380.0M$356.0M
Operating expenses and other$1.4B$991.0M$989.0M$1.0B$1.1B$1.0B
Payment for (Proceeds from) Other Investing Activity—$45.0M—$11.0M$37.0M-$35.0M
Payments for Repurchase of Common Stock$346.0M$394.0M$257.0M$55.0M$100.0M$31.0M
Payments For Repurchase Of Redeemable Noncontrolling Interest$5.0M$34.0M———$36.0M
Payments of Ordinary Dividends, Common Stock$13.0M$13.0M$13.0M$13.0M$13.0M$13.0M
Payments to Acquire Debt Securities, Available-for-Sale$1.4B$1.8B$2.0B$2.3B$1.1B$1.5B
Payments To Acquire Limited Partnership Interests$100.0M$78.0M$202.0M$60.0M$107.0M$83.0M
Payments to Acquire Property, Plant, and Equipment$174.0M$98.0M$134.0M$156.0M$191.0M$204.0M
Issuance of debt$10.0M———$907.0M$495.0M
Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-Sale$641.0M$814.0M$799.0M$954.0M$790.0M$813.0M
Financing — other-$14.0M-$23.0M-$40.0M-$6.0M$0.0-$23.0M
Sale of investments$458.0M$643.0M$854.0M$935.0M$514.0M$364.0M
Repayments of Debt$603.0M$1.0M$2.0M$1.0M$865.0M$1.1B
Add: dilutive effect of potential common shares (in shares)—$150.0K$120.0K$140.0K—$90.0K
Cash Dividends, Common Stock$13.0M$13.0M$13.0M$13.0M$13.0M$13.0M

Other Income & Expense

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Gain (Loss) on Investments-$39.0M-$9.0M-$46.0M-$7.0M-$19.0M-$18.0M
Gains on strategic investments, net-$39.0M-$9.0M-$46.0M-$7.0M-$19.0M-$18.0M
Income from equity method investments$14.0M-$1.0M$18.0M$22.0M$35.0M$37.0M
Gain (loss) on disposal of assets-$39.0M-$9.0M-$46.0M-$7.0M-$19.0M-$18.0M
Gains (losses) on equity investments-$39.0M-$9.0M-$46.0M-$7.0M-$19.0M-$18.0M
Interest expense$110.0M$105.0M$107.0M$112.0M$113.0M$113.0M
Gains on disposal of investments and other property-$39.0M-$9.0M-$46.0M-$7.0M-$19.0M-$18.0M

Net Income

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Common Stock Dividends$13.0M$13.0M$13.0M$13.0M$13.0M$13.0M
Net income$187.0M$370.0M$391.0M$504.0M$402.0M$337.0M
Common Stock Dividends$13.0M$13.0M$13.0M$13.0M$13.0M$13.0M

Operating Expenses

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Depreciation and amortization$145.8M$152.5M$152.5M$152.5M$152.5M—

Income Before Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income before income taxes$188.0M$514.0M$539.0M$689.0M$541.0M$463.0M

Tax

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Income tax expense$0.0$122.0M$123.0M$153.0M$113.0M$109.0M

Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Net premiums earned$2.7B$2.6B$2.7B$2.8B$2.8B$2.7B
Net investment income$696.0M$608.0M$714.0M$743.0M$714.0M$613.0M
Non-Insurance Warranty Revenue$397.0M$397.0M$398.0M$393.0M$389.0M$374.0M
Operating revenues and other$813.0M$872.0M$795.0M$759.0M$853.0M$887.0M
Total revenue$4.5B$4.5B$4.6B$4.7B$4.7B$4.6B

Cost of Revenue

MetricQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26
Medical costs$2.0B$2.0B$2.1B$2.0B$2.2B$2.2B